伦敦初创公司Limbic近日宣布成功完成1400万美元的A轮融资，此举将加速其人工智能治疗助理产品在美国市场的推广。本轮融资由知名风投机构Khosla Ventures领投，Gaingels和Illusian等投资者参投，彰显了资本市场对Limbic技术及应用前景的高度认可。
成立于2018年的Limbic，专注于研发人工智能心理健康聊天机器人和基于AI的临床转诊软件。其创新产品已经在英国的国家医疗服务体系（NHS）中广泛应用，覆盖了33%的谈话治疗服务，惠及约26万名患者。这一数字表明，Limbic的技术在改善心理健康服务效率和可达性方面已取得显著成果。
Limbic的AI聊天机器人通过模拟人类对话，为用户提供个性化的心理支持，而其临床转诊软件则能帮助医疗机构更精准地匹配患者需求，优化治疗流程。此次融资将为Limbic进一步优化产品、扩大市场规模、并深化与美国医疗体系的合作提供强有力的资金支持。
“我们非常荣幸能得到Khosla Ventures和其它投资者的信任，”Limbic的创始人表示，“这笔资金将使我们能够将成功的英国模式带到美国，帮助更多的人获得及时、有效的心理健康支持。我们致力于利用人工智能的力量，解决全球心理健康领域的挑战。”
随着心理健康问题日益引起社会关注，Limbic的AI解决方案有望成为未来医疗保健领域的一个重要突破，为全球患者提供更加便捷、个性化的治疗途径。
英语如下：
**News Title:** “London-based AI Mental Health Company Limbic Raises $14M to Expand in the US Market”
**Keywords:** AI therapy, Limbic, $14M funding
**News Content:** London-based startup Limbic has recently announced the successful completion of a $14 million Series A funding round, which will expedite the expansion of its AI therapy assistant products in the American market. The round was led by prominent venture capital firm Khosla Ventures, with participation from Gaingels and Illusian, indicating strong market confidence in Limbic’s technology and its future potential.
Founded in 2018, Limbic focuses on developing AI-powered mental health chatbots and clinical referral software. Its innovative products are widely employed within the UK’s National Health Service (NHS), servicing 33% of talking therapies and benefiting approximately 260,000 patients. This figure underscores the significant strides Limbic’s technology has made in enhancing mental health service efficiency and accessibility.
Limbic’s AI chatbots simulate human conversation to provide personalized mental health support, while its clinical referral software aids healthcare facilities in more accurately matching patients’ needs and optimizing treatment pathways. The new funding will bolster Limbic’s product refinement, market expansion, and deepening collaborations with the US healthcare system.
“We are thrilled to have the trust of Khosla Ventures and our other investors,” said the founder of Limbic, “This funding will enable us to bring our successful UK model to the US, helping more people access timely and effective mental health support. We are committed to leveraging the power of AI to address global mental health challenges.”
As mental health concerns gain increasing societal attention, Limbic’s AI-driven solutions are poised to be a significant breakthrough in future healthcare, offering more accessible and personalized treatment options for patients worldwide.
【来源】https://sifted.eu/articles/limbic-series-a-14m-ai-chatbot-news
Views: 1